Discover 382 paid clinical trials in Chesapeake, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 382
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Norfolk VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
Pediatric Post-Approval Registry
for
Obstructive Sleep Apnea
Location: Norfolk VA, Durham NC, Philadelphia PA, Sewickley PA,
Sponsor: Inspire Medical Systems, Inc.
Sex: All
Age: 18 - 21
Code: NCT04457154
Recruiting
Active & Responsive
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
for
Hyperphosphatemia,
Location: Norfolk VA, Ridgewood NY, Orange CT, Middlebury CT,
Sponsor: R1 Therapeutics
Sex: All
Age: 18+
Code: NCT06712654
Phase 2, Recruiting
Active & Responsive
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: Norfolk VA, Huntersville NC, Denver NC, Columbia SC,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase 2, Recruiting
Active & Responsive
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
for
Atopic Dermatitis (AD)
Location: Norfolk VA, Wilmington NC, Camp Hill PA, New York NY,
Sponsor: Enveda Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07298395
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Norfolk VA, Rockville MD, New York NY, Cromwell CT,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: Norfolk VA, Richmond VA, Morehead City NC, Raleigh NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase 3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Norfolk VA, Richmond VA, New Bern NC, Morehead City NC,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: Norfolk VA, Morehead City NC, Washington D.C. DC,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events
for
Cardiovascular Disease
Location: Norfolk VA, Midlothian VA, Kinston NC, Bowie MD,
Sponsor: Amgen
Sex: All
Age: 50 - 70+
Code: NCT07136012
Phase 3, Recruiting
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Norfolk VA, Hyattsville MD, Baltimore MD, Monroe NC,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
Study of ALK-001 on the Progression of Stargardt Disease
for
Stargardt Disease
Location: Norfolk VA, Fairfax VA, Pittsburgh PA, Erie PA,
Sponsor: Alkeus Pharmaceuticals, Inc.
Sex: All
Age: 8 - 45
Code: NCT07419334
Phase 3, Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: Norfolk VA, Rockville MD, The Bronx NY, Mississauga,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase 2, Recruiting
Active & Responsive
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
for
Healthy
Location: Norfolk VA, Richmond VA, Falls Church VA, Durham NC,
Sponsor: Pfizer
Sex: All
Age: 0 - 49
Code: NCT07160244
Phase 3, Recruiting
Active & Responsive
Phase 1 Study of Intravaginal KB15A
for
Healthy Subjects
Location: Norfolk VA
Sponsor: ZabBio Inc.
Sex: Female
Age: 18 - 45
Code: NCT07222020
Phase 1, Recruiting
Active & Responsive
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for
Lichen Planopilaris
Location: Norfolk VA, Richmond VA, Durham NC, Roanoke VA,
Sponsor: Priovant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07532603
Phase 2, Phase 3, Recruiting
Active & Responsive
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Virginia Beach VA, Raleigh NC, Burke VA,
Sponsor: Expedition Therapeutics, Inc
Sex: All
Age: 40 - 70+
Code: NCT07684820
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Chesapeake VA, Durham NC, Rockville MD, Philadelphia PA,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
for
Rheumatoid Arthritis
Location: Chesapeake VA, Duncansville PA, The Bronx NY,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07137598
Phase 2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Norfolk VA, Clinton MD, Washington D.C. DC,